News
January 16, 2009 - St. Jude Medical Inc. today said results from the landmark FAME (Fractional flow reserve (FFR) vs. Angiography in Multivessel Evaluation) study, which demonstrate a statistically significant 30 percent difference in major adverse cardiac events (MACE) such as death, myocardial infarction and repeat revascularization, was published in the New England Journal and Medicine.
January 15, 2009
News
January 16, 2009 - St. Jude Medical Inc. said its ViewMate II Ultrasound System with the ViewFlex PLUS Intracardiac ...
January 15, 2009News
Fluke Biomedical Gains FDA 510(k) Clearance for Impulse 7010 Defibrillator Selectable Load Accessory
January 16, 2009 – The FDA granted Fluke Biomedical U.S. Food and Drug 510(k) clearance for the Impulse 7010 ...
January 15, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
January 15, 2009 - Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in older ...
January 14, 2009News
January 15, 2009 - The six-month follow-up examination of a 64-year-old man enrolled in SECRITT I, a pilot study ...
January 14, 2009
Feature | Maureen Leahy-Patano
Is an evolution of sorts happening within advanced visualization?
January 14, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
January 14, 2009 - According to Millennium Research Group's (MRG's) U.S. Markets for Electrophysiology (EP) Mapping and ...
January 13, 2009News
January 14, 2009 - University of Ottawa Heart Institute (UOHI) researchers have successfully grown blood vessels in ...
January 13, 2009News
January 14, 2009 - Society of Nuclear (SNM) will devote its annual Molecular Imaging Summit to introducing the new SNM ...
January 13, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
January 13, 2009 - Micell Technologies, a development-stage biomedical device company dedicated to developing innovative interventional cardiology systems, has obtained the rights to Maxcor's CE-marked Genius MAGIC Cobalt Chromium Coronary Stent System for the purpose of developing and marketing drug-eluting stents (DES) based on Micell's prop coating technology.
January 12, 2009News
January 13, 2009 - Edwards Lifesciences Corp. said Jan. 9 the Patents Court in the United Kingdom upheld the validity of ...
January 12, 2009News
January 13, 2009 - Michigan CardioVascular Institute (MCVI), a twenty-two location cardiovascular group practice based ...
January 12, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
January 13, 2009 -W.L. Gore and Associates today said it received CE Mark of its GORE VIABAHN Endoprosthesis with ...
January 12, 2009News
January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the ...
January 12, 2009News
January 13, 2009 - Stereotaxis Inc. said the first crossing of a chronic total occlusion (CTO) using the RF PowerAssert ...
January 12, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now